Michael J Breslow Insider Trading $EICU VISICU INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael J Breslow.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael J Breslow. Michael J Breslow is EVP Clinical R&D in VISICU INC ($EICU).
Michael J Breslow in VISICU INC
Trading Symbol: EICUIndustry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of Michael J Breslow: EVP Clinical R&D
Holdings: 0 shares
Latest Transaction: Feb 22 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael J Breslow in VISICU INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | D | 10.18 | 65,000 | 661,700 | 0 | |
Feb 22 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | D | 5.67 | 50,000 | 283,500 | 0 | |
Feb 22 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | D | 1.80 | 50,000 | 90,000 | 0 | |
Feb 22 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | D | 0.90 | 25,000 | 22,500 | 0 | |
Feb 22 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | D | 0.35 | 50,000 | 17,500 | 0 | |
Feb 22 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | D | 0.35 | 25,000 | 8,750 | 0 | |
Feb 22 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | D | 0.35 | 100,000 | 35,000 | 0 | |
Feb 22 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | D | 0.90 | 25,000 | 22,500 | 0 | |
Feb 22 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | D | 12.00 | 603,753 | 7,245,036 | 0 | 603.8 K to 0 (-100.00 %) |
Feb 21 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Buy | J | 0.00 | 81,091 | 0 | 603,753 | 522.7 K to 603.8 K (+15.51 %) |
Feb 21 2008 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Gift | G | 0.00 | 169,647 | 0 | 603,753 | 773.4 K to 603.8 K (-21.94 %) |
Oct 09 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 50 | 400 | 250,738 | 250.8 K to 250.7 K (-0.02 %) |
Oct 09 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 50 | 400 | 522,662 | 522.7 K to 522.7 K (-0.01 %) |
Sep 25 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 2,500 | 20,000 | 250,788 | 253.3 K to 250.8 K (-0.99 %) |
Sep 25 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 2,500 | 20,000 | 522,712 | 525.2 K to 522.7 K (-0.48 %) |
Aug 07 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 2,011 | 16,088 | 253,288 | 255.3 K to 253.3 K (-0.79 %) |
Aug 07 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 2,011 | 16,088 | 525,212 | 527.2 K to 525.2 K (-0.38 %) |
Aug 07 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 489 | 3,912 | 255,299 | 255.8 K to 255.3 K (-0.19 %) |
Aug 07 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 489 | 3,912 | 527,223 | 527.7 K to 527.2 K (-0.09 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.10 | 500 | 4,550 | 255,788 | 256.3 K to 255.8 K (-0.20 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.11 | 375 | 3,416 | 256,288 | 256.7 K to 256.3 K (-0.15 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.12 | 975 | 8,892 | 256,663 | 257.6 K to 256.7 K (-0.38 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.13 | 400 | 3,652 | 257,638 | 258 K to 257.6 K (-0.16 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.14 | 100 | 914 | 258,038 | 258.1 K to 258 K (-0.04 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.16 | 100 | 916 | 258,138 | 258.2 K to 258.1 K (-0.04 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.17 | 50 | 459 | 258,238 | 258.3 K to 258.2 K (-0.02 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.10 | 500 | 4,550 | 527,712 | 528.2 K to 527.7 K (-0.09 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.11 | 375 | 3,416 | 528,212 | 528.6 K to 528.2 K (-0.07 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.12 | 975 | 8,892 | 528,587 | 529.6 K to 528.6 K (-0.18 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.13 | 400 | 3,652 | 529,562 | 530 K to 529.6 K (-0.08 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.14 | 100 | 914 | 529,962 | 530.1 K to 530 K (-0.02 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.16 | 100 | 916 | 530,062 | 530.2 K to 530.1 K (-0.02 %) |
Jul 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.17 | 50 | 459 | 530,162 | 530.2 K to 530.2 K (-0.01 %) |
Jun 08 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 1,625 | 16,250 | 258,288 | 259.9 K to 258.3 K (-0.63 %) |
Jun 08 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 1,625 | 16,250 | 530,212 | 531.8 K to 530.2 K (-0.31 %) |
Jun 01 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 2,850 | 28,500 | 264,138 | 267 K to 264.1 K (-1.07 %) |
Jun 01 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 2,850 | 28,500 | 536,062 | 538.9 K to 536.1 K (-0.53 %) |
Jun 01 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 1,300 | 13,000 | 266,988 | 268.3 K to 267 K (-0.48 %) |
Jun 01 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 1,300 | 13,000 | 538,912 | 540.2 K to 538.9 K (-0.24 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 1,725 | 17,250 | 259,913 | 261.6 K to 259.9 K (-0.66 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 1,725 | 17,250 | 531,837 | 533.6 K to 531.8 K (-0.32 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.72 | 500 | 4,860 | 261,638 | 262.1 K to 261.6 K (-0.19 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.73 | 500 | 4,865 | 262,138 | 262.6 K to 262.1 K (-0.19 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.75 | 500 | 4,875 | 262,638 | 263.1 K to 262.6 K (-0.19 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.76 | 50 | 488 | 263,138 | 263.2 K to 263.1 K (-0.02 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.77 | 145 | 1,417 | 263,188 | 263.3 K to 263.2 K (-0.06 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.78 | 450 | 4,401 | 263,333 | 263.8 K to 263.3 K (-0.17 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.79 | 105 | 1,028 | 263,783 | 263.9 K to 263.8 K (-0.04 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.80 | 150 | 1,470 | 263,888 | 264 K to 263.9 K (-0.06 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.81 | 50 | 491 | 264,038 | 264.1 K to 264 K (-0.02 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.82 | 50 | 491 | 264,088 | 264.1 K to 264.1 K (-0.02 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.72 | 500 | 4,860 | 533,562 | 534.1 K to 533.6 K (-0.09 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.73 | 500 | 4,865 | 534,062 | 534.6 K to 534.1 K (-0.09 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.75 | 500 | 4,875 | 534,562 | 535.1 K to 534.6 K (-0.09 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.76 | 50 | 488 | 535,062 | 535.1 K to 535.1 K (-0.01 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.77 | 145 | 1,417 | 535,112 | 535.3 K to 535.1 K (-0.03 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.78 | 450 | 4,401 | 535,257 | 535.7 K to 535.3 K (-0.08 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.79 | 105 | 1,028 | 535,707 | 535.8 K to 535.7 K (-0.02 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.80 | 150 | 1,470 | 535,812 | 536 K to 535.8 K (-0.03 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.81 | 50 | 491 | 535,962 | 536 K to 536 K (-0.01 %) |
Jun 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 9.82 | 50 | 491 | 536,012 | 536.1 K to 536 K (-0.01 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.51 | 50 | 426 | 268,288 | 268.3 K to 268.3 K (-0.02 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.52 | 200 | 1,704 | 268,338 | 268.5 K to 268.3 K (-0.07 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.54 | 250 | 2,135 | 268,538 | 268.8 K to 268.5 K (-0.09 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.57 | 24 | 206 | 268,788 | 268.8 K to 268.8 K (-0.01 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.58 | 250 | 2,145 | 268,812 | 269.1 K to 268.8 K (-0.09 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.59 | 250 | 2,148 | 269,062 | 269.3 K to 269.1 K (-0.09 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.60 | 226 | 1,944 | 269,312 | 269.5 K to 269.3 K (-0.08 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.63 | 250 | 2,158 | 269,538 | 269.8 K to 269.5 K (-0.09 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.69 | 250 | 2,173 | 269,788 | 270 K to 269.8 K (-0.09 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.70 | 500 | 4,350 | 270,038 | 270.5 K to 270 K (-0.18 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.81 | 150 | 1,322 | 270,538 | 270.7 K to 270.5 K (-0.06 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.82 | 100 | 882 | 270,688 | 270.8 K to 270.7 K (-0.04 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.51 | 50 | 426 | 540,212 | 540.3 K to 540.2 K (-0.01 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.52 | 200 | 1,704 | 540,262 | 540.5 K to 540.3 K (-0.04 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.54 | 250 | 2,135 | 540,462 | 540.7 K to 540.5 K (-0.05 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.57 | 24 | 206 | 540,712 | 540.7 K to 540.7 K (0.00 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.58 | 250 | 2,145 | 540,736 | 541 K to 540.7 K (-0.05 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.59 | 250 | 2,148 | 540,986 | 541.2 K to 541 K (-0.05 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.60 | 226 | 1,944 | 541,236 | 541.5 K to 541.2 K (-0.04 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.63 | 250 | 2,158 | 541,462 | 541.7 K to 541.5 K (-0.05 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.69 | 250 | 2,173 | 541,712 | 542 K to 541.7 K (-0.05 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.70 | 500 | 4,350 | 541,962 | 542.5 K to 542 K (-0.09 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.81 | 150 | 1,322 | 542,462 | 542.6 K to 542.5 K (-0.03 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.82 | 100 | 882 | 542,612 | 542.7 K to 542.6 K (-0.02 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 1,000 | 10,000 | 270,788 | 271.8 K to 270.8 K (-0.37 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.08 | 1,000 | 10,080 | 271,788 | 272.8 K to 271.8 K (-0.37 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.10 | 500 | 5,050 | 272,788 | 273.3 K to 272.8 K (-0.18 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 1,000 | 10,000 | 542,712 | 543.7 K to 542.7 K (-0.18 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.08 | 1,000 | 10,080 | 543,712 | 544.7 K to 543.7 K (-0.18 %) |
May 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.10 | 500 | 5,050 | 544,712 | 545.2 K to 544.7 K (-0.09 %) |
Apr 24 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 4,796 | 38,368 | 273,288 | 278.1 K to 273.3 K (-1.72 %) |
Apr 24 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 4,796 | 38,368 | 545,212 | 550 K to 545.2 K (-0.87 %) |
Mar 27 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 204 | 1,632 | 278,084 | 278.3 K to 278.1 K (-0.07 %) |
Mar 27 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 8.00 | 204 | 1,632 | 550,008 | 550.2 K to 550 K (-0.04 %) |
Mar 27 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | J | 0.00 | 101,712 | 0 | 278,288 | 380 K to 278.3 K (-26.77 %) |
Mar 27 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Buy | J | 0.00 | 101,712 | 0 | 550,212 | 448.5 K to 550.2 K (+22.68 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Option Exercise | A | 10.18 | 65,000 | 661,700 | 65,000 | |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.23 | 500 | 5,115 | 380,000 | 380.5 K to 380 K (-0.13 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.27 | 50 | 514 | 380,500 | 380.6 K to 380.5 K (-0.01 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.28 | 500 | 5,140 | 380,550 | 381.1 K to 380.6 K (-0.13 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.31 | 1,700 | 17,527 | 381,050 | 382.8 K to 381.1 K (-0.44 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.34 | 250 | 2,585 | 382,750 | 383 K to 382.8 K (-0.07 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.36 | 250 | 2,590 | 383,000 | 383.3 K to 383 K (-0.07 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.37 | 500 | 5,185 | 383,250 | 383.8 K to 383.3 K (-0.13 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.38 | 100 | 1,038 | 383,750 | 383.9 K to 383.8 K (-0.03 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.39 | 700 | 7,273 | 383,850 | 384.6 K to 383.9 K (-0.18 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.40 | 300 | 3,120 | 384,550 | 384.9 K to 384.6 K (-0.08 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.42 | 150 | 1,563 | 384,850 | 385 K to 384.9 K (-0.04 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.23 | 500 | 5,115 | 448,500 | 449 K to 448.5 K (-0.11 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.27 | 50 | 514 | 449,000 | 449.1 K to 449 K (-0.01 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.28 | 500 | 5,140 | 449,050 | 449.6 K to 449.1 K (-0.11 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.31 | 1,700 | 17,527 | 449,550 | 451.3 K to 449.6 K (-0.38 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.34 | 250 | 2,585 | 451,250 | 451.5 K to 451.3 K (-0.06 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.36 | 250 | 2,590 | 451,500 | 451.8 K to 451.5 K (-0.06 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.37 | 500 | 5,185 | 451,750 | 452.3 K to 451.8 K (-0.11 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.38 | 100 | 1,038 | 452,250 | 452.4 K to 452.3 K (-0.02 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.39 | 700 | 7,273 | 452,350 | 453.1 K to 452.4 K (-0.15 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.40 | 300 | 3,120 | 453,050 | 453.4 K to 453.1 K (-0.07 %) |
Feb 02 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.42 | 150 | 1,563 | 453,350 | 453.5 K to 453.4 K (-0.03 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 900 | 9,000 | 385,000 | 385.9 K to 385 K (-0.23 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.13 | 50 | 507 | 385,900 | 386 K to 385.9 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.14 | 350 | 3,549 | 385,950 | 386.3 K to 386 K (-0.09 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.15 | 295 | 2,994 | 386,300 | 386.6 K to 386.3 K (-0.08 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.16 | 100 | 1,016 | 386,595 | 386.7 K to 386.6 K (-0.03 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.17 | 250 | 2,543 | 386,695 | 386.9 K to 386.7 K (-0.06 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.18 | 350 | 3,563 | 386,945 | 387.3 K to 386.9 K (-0.09 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.19 | 55 | 560 | 387,295 | 387.4 K to 387.3 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.21 | 200 | 2,042 | 387,350 | 387.6 K to 387.4 K (-0.05 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.22 | 100 | 1,022 | 387,550 | 387.7 K to 387.6 K (-0.03 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.00 | 900 | 9,000 | 453,500 | 454.4 K to 453.5 K (-0.20 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.13 | 50 | 507 | 454,400 | 454.5 K to 454.4 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.14 | 350 | 3,549 | 454,450 | 454.8 K to 454.5 K (-0.08 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.15 | 294 | 2,984 | 454,800 | 455.1 K to 454.8 K (-0.06 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.16 | 100 | 1,016 | 455,094 | 455.2 K to 455.1 K (-0.02 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.17 | 250 | 2,543 | 455,194 | 455.4 K to 455.2 K (-0.05 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.18 | 350 | 3,563 | 455,444 | 455.8 K to 455.4 K (-0.08 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.19 | 56 | 571 | 455,794 | 455.9 K to 455.8 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.21 | 200 | 2,042 | 455,850 | 456.1 K to 455.9 K (-0.04 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.22 | 100 | 1,022 | 456,050 | 456.2 K to 456.1 K (-0.02 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.24 | 50 | 512 | 387,650 | 387.7 K to 387.7 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.25 | 50 | 513 | 387,700 | 387.8 K to 387.7 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.26 | 50 | 513 | 387,750 | 387.8 K to 387.8 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.27 | 13 | 134 | 387,800 | 387.8 K to 387.8 K (0.00 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.28 | 50 | 514 | 387,813 | 387.9 K to 387.8 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.29 | 100 | 1,029 | 387,863 | 388 K to 387.9 K (-0.03 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.30 | 250 | 2,575 | 387,963 | 388.2 K to 388 K (-0.06 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.31 | 50 | 516 | 388,213 | 388.3 K to 388.2 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.32 | 50 | 516 | 388,263 | 388.3 K to 388.3 K (-0.01 %) |
Jan 05 2007 | EICU | VISICU INC | Breslow Michael J | EVP Clinical R&D | Sell | S | 10.34 | 50 | 517 | 388,313 | 388.4 K to 388.3 K (-0.01 %) |